Skip to main content
. 2018 Jun 12;2(11):1315–1324. doi: 10.1182/bloodadvances.2018018036

Figure 3.

Figure 3.

Thrombin decay capacity in APS patients and control subjects. Thrombin decay capacity was assessed in healthy control subjects and APS patients without VKA therapy. No significant differences were detected between groups using a 2-sided Mann-Whitney U test.